Evidence map›Paper›PMID 42100503›Full record

ArticleInternational journal of women's health2026

Acupuncture for Premature Ovarian Insufficiency: A Randomized, Non-Inferiority Protocol with Exploratory Epigenetics Analysis.

Yu Luo, Suning Huang, Haichuan Xie, Bei Zhang, Fei Ma, Yanting Lin, Yan Ning, Jiaman Wu

Abstract read
In one paragraph

Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yu LuoGraduate School, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, People's Republic of China.
Suning HuangGraduate School, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, People's Republic of China.
Haichuan XieShenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, Guangdong, 518000, People's Republic of China.
Bei ZhangShenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, Guangdong, 518000, People's Republic of China.
Fei MaGraduate School, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, People's Republic of China.
Yanting LinGraduate School, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, People's Republic of China.
Yan NingGraduate School, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, People's Republic of China.
Jiaman WuGraduate School, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Premature ovarian insufficiency (POI), characterized by the loss of ovarian function before age 40, significantly impairs reproductive health. While Hormone Replacement Therapy (HRT) remains the standard of care, its efficacy is often limited by incomplete functional restoration and potential adverse effects. Acupuncture has emerged as a promising adjunct; however, robust clinical evidence and a clear mechanistic understanding are currently lacking. This study aims to evaluate the non-inferiority of acupuncture compared to HRT in improving clinical pregnancy rates among women with POI, while concurrently exploring potential epigenetic mechanisms, specifically DNA methylation. Methods: This is a randomized, controlled, non-inferiority trial. A total of 572 participants with POI undergoing assisted reproductive technology (ART) will be recruited and randomized to receive either a standardized acupuncture protocol or HRT (following 2024 ESHRE guidelines). Additionally, 286 women with normal ovarian function undergoing in vitro fertilization and embryo transfer (IVF-ET) for male-factor or tubal infertility will be enrolled as a baseline control group for epigenetic analysis. The primary outcome is the clinical pregnancy rate. Secondary outcomes include serum sex hormones, ovarian reserve markers, ovulation induction parameters, pregnancy outcomes, the Modified Kupperman Index, and DNA methylation profiles in ovarian granulosa cells, characterized via whole-genome bisulfite sequencing (WGBS). Discussion: This protocol is designed to establish clinical evidence regarding the non-inferiority of acupuncture to HRT for POI management. Furthermore, the exploratory epigenetic analysis seeks to elucidate the underlying molecular mechanisms, potentially identifying DNA methylation as a key regulatory pathway.

Indexed as

acupunctureepigeneticshormone replacement therapynon-inferiority trialpremature ovarian insufficiency

Identifiers

PMID42100503
PMCPMC13148264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.